White House backs limited Medicare drug reform legislation

The White House is backing a limited set of Medicare drug pricing reforms and hopes to have them included in legislation that is slated for enactment

Read the full 267 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE